Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > CHD7(Gene name) > Human
  • Add your favorite
  • CHD7 (Gene name),
  • Chromodomain-helicase-DNA-binding protein 7 (Protein name ),  CHD7_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    CHD7(KIAA1416);
    Protein name:
    Chromodomain-helicase-DNA-binding protein 7(CHD-7);
    Alternative:
    ATP-dependent helicase CHD7;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    May interact with CTCF.
    Function:
    Probable transcription regulator.
    Subcellular Location:
    Nucleus
    Protein Attributes:
    Sequence length:
    2997
    Sequence:
    50:
    MADPGMMSLF | GEDGNIFSEG | LEGLGECGYP | ENPVNPMGQQ | MPIDQGFASL | 
    100:
    QPSLHHPSTN | QNQTKLTHFD | HYNQYEQQKM | HLMDQPNRMM | SNTPGNGLAS | 
    150:
    PHSQYHTPPV | PQVPHGGSGG | GQMGVYPGMQ | NERHGQSFVD | SSSMWGPRAV | 
    200:
    QVPDQIRAPY | QQQQPQPQPP | QPAPSGPPAQ | GHPQHMQQMG | SYMARGDFSM | 
    250:
    QQHGQPQQRM | SQFSQGQEGL | NQGNPFIATS | GPGHLSHVPQ | QSPSMAPSLR | 
    300:
    HSVQQFHHHP | STALHGESVA | HSPRFSPNPP | QQGAVRPQTL | NFSSRSQTVP | 
    350:
    SPTINNSGQY | SRYPYSNLNQ | GLVNNTGMNQ | NLGLTNNTPM | NQSVPRYPNA | 
    400:
    VGFPSNSGQG | LMHQQPIHPS | GSLNQMNTQT | MHPSQPQGTY | ASPPPMSPMK | 
    450:
    AMSNPAGTPP | PQVRPGSAGI | PMEVGSYPNM | PHPQPSHQPP | GAMGIGQRNM | 
    500:
    GPRNMQQSRP | FIGMSSAPRE | LTGHMRPNGC | PGVGLGDPQA | IQERLIPGQQ | 
    550:
    HPGQQPSFQQ | LPTCPPLQPH | PGLHHQSSPP | HPHHQPWAQL | HPSPQNTPQK | 
    600:
    VPVHQHSPSE | PFLEKPVPDM | TQVSGPNAQL | VKSDDYLPSI | EQQPQQKKKK | 
    650:
    KKNNHIVAED | PSKGFGKDDF | PGGVDNQELN | RNSLDGSQEE | KKKKKRSKAK | 
    700:
    KDPKEPKEPK | EKKEPKEPKT | PKAPKIPKEP | KEKKAKTATP | KPKSSKKSSN | 
    750:
    KKPDSEASAL | KKKVNKGKTE | GSENSDLDKT | PPPSPPPEED | EDPGVQKRRS | 
    800:
    SRQVKRKRYT | EDLEFKISDE | EADDADAAGR | DSPSNTSQSE | QQESVDAEGP | 
    850:
    VVEKIMSSRS | VKKQKESGEE | VEIEEFYVKY | KNFSYLHCQW | ASIEDLEKDK | 
    900:
    RIQQKIKRFK | AKQGQNKFLS | EIEDELFNPD | YVEVDRIMDF | ARSTDDRGEP | 
    950:
    VTHYLVKWCS | LPYEDSTWER | RQDIDQAKIE | EFEKLMSREP | ETERVERPPA | 
    1000:
    DDWKKSESSR | EYKNNNKLRE | YQLEGVNWLL | FNWYNMRNCI | LADEMGLGKT | 
    1050:
    IQSITFLYEI | YLKGIHGPFL | VIAPLSTIPN | WEREFRTWTE | LNVVVYHGSQ | 
    1100:
    ASRRTIQLYE | MYFKDPQGRV | IKGSYKFHAI | ITTFEMILTD | CPELRNIPWR | 
    1150:
    CVVIDEAHRL | KNRNCKLLEG | LKMMDLEHKV | LLTGTPLQNT | VEELFSLLHF | 
    1200:
    LEPSRFPSET | TFMQEFGDLK | TEEQVQKLQA | ILKPMMLRRL | KEDVEKNLAP | 
    1250:
    KEETIIEVEL | TNIQKKYYRA | ILEKNFTFLS | KGGGQANVPN | LLNTMMELRK | 
    1300:
    CCNHPYLING | AEEKILEEFK | ETHNAESPDF | QLQAMIQAAG | KLVLIDKLLP | 
    1350:
    KLKAGGHRVL | IFSQMVRCLD | ILEDYLIQRR | YPYERIDGRV | RGNLRQAAID | 
    1400:
    RFSKPDSDRF | VFLLCTRAGG | LGINLTAADT | CIIFDSDWNP | QNDLQAQARC | 
    1450:
    HRIGQSKSVK | IYRLITRNSY | EREMFDKASL | KLGLDKAVLQ | SMSGRENATN | 
    1500:
    GVQQLSKKEI | EDLLRKGAYG | ALMDEEDEGS | KFCEEDIDQI | LLRRTHTITI | 
    1550:
    ESEGKGSTFA | KASFVASGNR | TDISLDDPNF | WQKWAKKAEL | DIDALNGRNN | 
    1600:
    LVIDTPRVRK | QTRLYSAVKE | DELMEFSDLE | SDSEEKPCAK | PRRPQDKSQG | 
    1650:
    YARSECFRVE | KNLLVYGWGR | WTDILSHGRY | KRQLTEQDVE | TICRTILVYC | 
    1700:
    LNHYKGDENI | KSFIWDLITP | TADGQTRALV | NHSGLSAPVP | RGRKGKKVKA | 
    1750:
    QSTQPVVQDA | DWLASCNPDA | LFQEDSYKKH | LKHHCNKVLL | RVRMLYYLRQ | 
    1800:
    EVIGDQADKI | LEGADSSEAD | VWIPEPFHAE | VPADWWDKEA | DKSLLIGVFK | 
    1850:
    HGYEKYNSMR | ADPALCFLER | VGMPDAKAIA | AEQRGTDMLA | DGGDGGEFDR | 
    1900:
    EDEDPEYKPT | RTPFKDEIDE | FANSPSEDKE | ESMEIHATGK | HSESNAELGQ | 
    1950:
    LYWPNTSTLT | TRLRRLITAY | QRSYKRQQMR | QEALMKTDRR | RRRPREEVRA | 
    2000:
    LEAEREAIIS | EKRQKWTRRE | EADFYRVVST | FGVIFDPVKQ | QFDWNQFRAF | 
    2050:
    ARLDKKSDES | LEKYFSCFVA | MCRRVCRMPV | KPDDEPPDLS | SIIEPITEER | 
    2100:
    ASRTLYRIEL | LRKIREQVLH | HPQLGERLKL | CQPSLDLPEW | WECGRHDRDL | 
    2150:
    LVGAAKHGVS | RTDYHILNDP | ELSFLDAHKN | FAQNRGAGNT | SSLNPLAVGF | 
    2200:
    VQTPPVISSA | HIQDERVLEQ | AEGKVEEPEN | PAAKEKCEGK | EEEEETDGSG | 
    2250:
    KESKQECEAE | ASSVKNELKG | VEVGADTGSK | SISEKGSEED | EEEKLEDDDK | 
    2300:
    SEESSQPEAG | AVSRGKNFDE | ESNASMSTAR | DETRDGFYME | DGDPSVAQLL | 
    2350:
    HERTFAFSFW | PKDRVMINRL | DNICEAVLKG | KWPVNRRQMF | DFQGLIPGYT | 
    2400:
    PTTVDSPLQK | RSFAELSMVG | QASISGSEDI | TTSPQLSKED | ALNLSVPRQR | 
    2450:
    RRRRRKIEIE | AERAAKRRNL | MEMVAQLRES | QVVSENGQEK | VVDLSKASRE | 
    2500:
    ATSSTSNFSS | LSSKFILPNV | STPVSDAFKT | QMELLQAGLS | RTPTRHLLNG | 
    2550:
    SLVDGEPPMK | RRRGRRKNVE | GLDLLFMSHK | RTSLSAEDAE | VTKAFEEDIE | 
    2600:
    TPPTRNIPSP | GQLDPDTRIP | VINLEDGTRL | VGEDAPKNKD | LVEWLKLHPT | 
    2650:
    YTVDMPSYVP | KNADVLFSSF | QKPKQKRHRC | RNPNKLDINT | LTGEERVPVV | 
    2700:
    NKRNGKKMGG | AMAPPMKDLP | RWLEENPEFA | VAPDWTDIVK | QSGFVPESMF | 
    2750:
    DRLLTGPVVR | GEGASRRGRR | PKSEIARAAA | AAAAVASTSG | INPLLVNSLF | 
    2800:
    AGMDLTSLQN | LQNLQSLQLA | GLMGFPPGLA | TAATAGGDAK | NPAAVLPLML | 
    2850:
    PGMAGLPNVF | GLGGLLNNPL | SAATGNTTTA | SSQGEPEDST | SKGEEKGNEN | 
    2900:
    EDENKDSEKS | TDAVSAADSA | NGSVGAATAP | AGLPSNPLAF | NPFLLSTMAP | 
    2950:
    GLFYPSMFLP | PGLGGLTLPG | FPALAGLQNA | VGSSEEKAAD | KAEGGPFKDG | 
    2997:
    ETLEGSDAEE | SLDKTAESSL | LEDEIAQGEE | LDSLDGGDEI | ENNENDE
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    Pfam:
    MIM:
    UniGene:
    String:
    KEGG:
    SMR:
    MIM:
    Uniprot:
     
    FOR
    ELISA Kit for Human CHD-7
    ELISA Kit for Human CHD-7
    ELISA Kit for Human CHD-7
    CLIA Kit for Human CHD-7
    CLIA Kit for Human CHD-7
    CLIA Kit for Human CHD-7
    Polyclonal Antibody for Human CHD-7
    Polyclonal Antibody for Human CHD-7
    Polyclonal Antibody for Human CHD-7
    Monoclonal Antibody for Human CHD-7
    Monoclonal Antibody for Human CHD-7
    Monoclonal Antibody for Human CHD-7
    Protein for Human CHD-7
    Protein for Human CHD-7
    Protein for Human CHD-7

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Cloning and chracterization of a novel alternatively spliced transcript of the human putative helicase CHD7."
      Colin C. , Correa R.G. , Tobaruella F.S. , Sogayar M.C. , Demasi M.A.
      Submitted (2009-10) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4);ALTERNATIVE SPLICING
    2. 3.
      "Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro."
      Nagase T. , Kikuno R. , Ishikawa K. , Hirosawa M. , Ohara O.
      DNA Res.7:65-73(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 763-2729 (ISOFORM 1)
      tissue: Brain.
    3. 4.
      "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones."
      Nakajima D. , Okazaki N. , Yamakawa H. , Kikuno R. , Ohara O. , Nagase T.
      DNA Res.9:99-106(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SEQUENCE REVISION
    4. 5.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 853-2997 (ISOFORM 2);NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2305-2997 (ISOFORM 1)
      tissue: Hepatoma.
    5. 6.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-639 AND 763-2997 (ISOFORM 1)
      tissue: Blood.
      tissue: Brain.
      tissue: Eye.
      tissue: Lung.
      tissue: Placenta.
      tissue: Skin.
    6. 7.
      "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage."
      Matsuoka S. , Ballif B.A. , Smogorzewska A. , McDonald E.R. III , Hurov K.E. , Luo J. , Bakalarski C.E. , Zhao Z. , Solimini N. , Lerenthal Y. , Shiloh Y. , Gygi S.P. , Elledge S.J.
      Science316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Embryonic kidney.
    7. 8.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2356; SER-2533; THR-2551 AND SER-2559;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    8. 9.
      "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
      Mayya V. , Lundgren D.H. , Hwang S.-I. , Rezaul K. , Wu L. , Eng J.K. , Rodionov V. , Han D.K.
      Sci. Signal.2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2559;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Leukemic T-cell.
    9. 10.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH CHD8;SUBCELLULAR LOCATION;CHARACTERIZATION OF VARIANTS CHARGES ARG-2091; ARG-2096 AND ARG-2108;CHARACTERIZATION OF VARIANT ILE-2102
    10. 11.
      "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
      Olsen J.V. , Vermeulen M. , Santamaria A. , Kumar C. , Miller M.L. , Jensen L.J. , Gnad F. , Cox J. , Jensen T.S. , Nigg E.A. , Brunak S. , Mann M.
      Sci. Signal.3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1874; SER-2251; SER-2395; THR-2472; SER-2533; THR-2551; SER-2559; SER-2619; SER-2956 AND SER-2961;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    11. 12.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    12. 13.
      "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."
      Rigbolt K.T. , Prokhorova T.A. , Akimov V. , Henningsen J. , Johansen P.T. , Kratchmarova I. , Kassem M. , Mann M. , Olsen J.V. , Blagoev B.
      Sci. Signal.4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-637; SER-725; SER-1577; SER-1581; SER-1874; SER-2231; SER-2233; SER-2237; SER-2251; SER-2272; SER-2275; SER-2533; SER-2535; SER-2559; SER-2956 AND SER-2961;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    13. 14.
      "Identification of CHD7S as a novel splicing variant of CHD7 with functions similar and antagonistic to those of the full-length CHD7L."
      Kita Y. , Nishiyama M. , Nakayama K.I.
      Genes Cells17:536-547(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ALTERNATIVE SPLICING (ISOFORM 3);FUNCTION;SUBCELLULAR LOCATION;TISSUE SPECIFICITY
    14. 15.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS LEU-466; VAL-511; VAL-522; ALA-527; PRO-1745; LYS-2077; ILE-2102; MET-2112 AND CYS-2319
    15. 16.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CHARGES CYS-840; SER-1020; VAL-1028; ARG-1031; ASN-1082; ARG-1101; ARG-1214; PRO-1292; ARG-1318; HIS-1345; SER-1684; VAL-1797; HIS-1812; GLY-1812; PRO-1815; ARG-2091; ARG-2108 AND ALA-2286;VARIANTS LEU-37; CYS-72; ALA-93; PRO-99; LEU-167; LEU-238; GLU-254; GLY-286; SER-439; PRO-524; ALA-558; LYS-596; GLY-699; SER-744; ASN-812; ALA-942; HIS-944; ARG-975; SER-1081; ARG-1251; CYS-1317; SER-1594; ASP-1617; VAL-1619; VAL-1672; GLY-1866; GLY-1972; TRP-2062; PRO-2074; GLY-2097; ILE-2102; MET-2112; ASP-2118; THR-2225; THR-2259; THR-2312; ALA-2330; ARG-2366; SER-2415; GLU-2464; ASP-2488; CYS-2491; GLN-2653; VAL-2725; LEU-2750; VAL-2780; THR-2789 AND ALA-2857
    16. 17.
      "Solution structure of the BRK domains from CHD7."
      Allen M.D. , Religa T.L. , Freund S.M. , Bycroft M.
      J. Mol. Biol.371:1135-1140(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 2561-2715;INTERACTION WITH CTCF
    17. 18.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CHARGES VAL-1028 AND ARG-1257;TISSUE SPECIFICITY
    18. 19.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CHARGES GLY-1031; ARG-1214; PRO-1294; PRO-1815; ARG-2096 AND SER-2319
    19. 20.
      "CHD7 gene polymorphisms are associated with susceptibility to idiopathic scoliosis."
      Gao X. , Gordon D. , Zhang D. , Browne R. , Helms C. , Gillum J. , Weber S. , Devroy S. , Swaney S. , Dobbs M. , Morcuende J. , Sheffield V. , Lovett M. , Bowcock A. , Herring J. , Wise C.
      Am. J. Hum. Genet.80:957-965(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN SUSCEPTIBILITY TO IS3
    20. 21.
      "Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome."
      Kim H.-G. , Kurth I. , Lan F. , Meliciani I. , Wenzel W. , Eom S.H. , Kang G.B. , Rosenberger G. , Tekin M. , Ozata M. , Bick D.P. , Sherins R.J. , Walker S.L. , Shi Y. , Gusella J.F. , Layman L.C.
      Am. J. Hum. Genet.83:511-519(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HH5 ARG-55; PHE-834; LEU-2880 AND GLU-2948;VARIANT THR-2789
    21. 22.
      "Familial CHARGE syndrome and the CHD7 gene: a recurrent missense mutation, intrafamilial recurrence and variability."
      Jongmans M.C. , Hoefsloot L.H. , van der Donk K.P. , Admiraal R.J. , Magee A. , van de Laar I. , Hendriks Y. , Verheij J.B. , Walpole I. , Brunner H.G. , van Ravenswaaij C.M.
      Am. J. Med. Genet. A146:43-50(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CHARGES ARG-2108
    22. 23.
      "Mutations in the CHD7 gene: the experience of a commercial laboratory."
      Bartels C.F. , Scacheri C. , White L. , Scacheri P.C. , Bale S.
      Genet. Test. Mol. Biomarkers14:881-891(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CHARGES ASP-871; VAL-1028; PRO-1294; HIS-1395; SER-1684; ARG-1739 AND ASN-2116;VARIANTS ILE-41; ARG-86; THR-103; ARG-201; MET-238; VAL-340; ALA-369; LEU-466; VAL-522; ALA-558; VAL-636; THR-699; ASN-728; SER-744; ALA-894; THR-907; MET-917; LYS-938; HIS-944; GLN-947; GLN-1203; ASP-1208; PRO-1322; CYS-1345; ARG-1416; GLN-1457; CYS-1576; SER-1617; GLU-1791; GLY-1866; THR-1950; HIS-2065; GLY-2084; ASP-2103; THR-2160; THR-2225; CYS-2319; ALA-2330; SER-2495; LEU-2527; SER-2683; CYS-2702; THR-2733; VAL-2806; ALA-2857; MET-2931 AND PHE-2984
    23. 24.
      "CHD7 mutational analysis and clinical considerations for auditory rehabilitation in deaf patients with CHARGE syndrome."
      Song M.H. , Cho H.J. , Lee H.K. , Kwon T.J. , Lee W.S. , Oh S. , Bok J. , Choi J.Y. , Kim U.K.
      PLoS ONE6:E24511-E24511(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CHARGES SER-2065
    24. 25.
      "Phenotype in 18 Danish subjects with genetically verified CHARGE syndrome."
      Husu E. , Hove H. , Farholt S. , Bille M. , Tranebjaerg L. , Vogel I. , Kreiborg S.
      Clin. Genet.83:125-134(2013) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CHARGES SER-1684 AND GLY-2418;VARIANT GLN-2653
    25. 26.
      "CHD7 mutations causing CHARGE syndrome are predominantly of paternal origin."
      Pauli S. , von Velsen N. , Burfeind P. , Steckel M. , Manz J. , Buchholz A. , Borozdin W. , Kohlhase J.
      Clin. Genet.81:234-239(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CHARGES SER-1020 AND ASP-1802
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter